Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe thigh is one of three licensed sites for a Wegovy injection, and for many people it becomes the most practical spot: you can see exactly what you're doing, there's usually enough subcutaneous tissue, and you don't need anyone else in the room. Wegovy (semaglutide) is a once-weekly prescription injection for weight management in adults, and the outer thigh works well for most people who have been trained on how to use it. This page explains the technique, what the first few injections feel like, and when to call your prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
You've just taken your Wegovy pen out of the fridge and let it sit at room temperature for about 30 minutes, as the Patient Information Leaflet advises. You're sitting down, leg relaxed, which is exactly the right call, injecting into tense muscle pulls the subcutaneous layer tight and makes the whole thing harder. The target is the outer, front-facing part of the thigh: roughly the middle third, running between your knee and hip. That zone tends to have a reasonable layer of subcutaneous fat even in leaner patients, and it keeps the needle well clear of blood vessels that run deeper along the inner thigh.
Clean the chosen spot with an alcohol swab and let it air dry, injecting through wet skin can sting more than it should. Hold the pen firmly but without gripping it like a pencil; the Wegovy pre-filled pen is designed to deliver the dose when you press the injection button, and fighting the device rarely helps. Press the pen flat against the skin so the needle goes in at 90 degrees, activate the button, and hold for the count your leaflet specifies (typically around ten seconds). That pause lets the full dose dispense before you lift away.
A short, dull ache at the site is normal. So is a small red mark that fades within an hour. If you see blood, apply gentle pressure; it's usually a tiny surface capillary and resolves quickly. Detailed guidance on exactly what you'll feel at each stage is covered in our step-by-step thigh injection guide, which walks through the process in sequence.
Injecting into the same small area every week causes a problem called lipohypertrophy: a build-up of scar-like fatty tissue under the skin. It is painless at first, which is exactly why people keep returning to a site that doesn't sting. The catch is that scar tissue absorbs semaglutide inconsistently, and erratic absorption is one of the more avoidable reasons for unpredictable results on treatment.
The fix is simple in principle: move at least two to three centimetres from last week's spot. Most people divide the outer thigh into an imaginary grid, working their way across it before switching to the other leg, or alternating between thighs and the abdomen on a pattern they can remember. Some people tie it to the calendar, injecting their Monday dose in the same rough zone each week but shifting location within it. The thigh injection site overview has a practical diagram approach if you want a visual reference for planning rotation.
The NHS guidance on weight-loss injections and semaglutide notes that rotating sites is a standard requirement for subcutaneous medicines and isn't optional advice. Your prescriber will ask about this at your follow-up review, so it's worth keeping a simple note of where you injected.
Most side effects from a Wegovy thigh injection are local and brief. A small bruise, mild tenderness for a day or two, or a tiny firmness under the skin are all recognised reactions that settle without any intervention. Nausea after the injection is a systemic effect of semaglutide rather than a thigh-specific problem, it tends to be most noticeable in the first week or two at each dose level and improves as your body adjusts. More on managing the early weeks of thigh injections, including why some patients find timing the dose with a light meal helps.
Contact your prescriber or call 111 if you notice: redness, warmth or swelling that spreads from the injection site rather than fading; a hard lump that doesn't shrink after a week; or any signs of an allergic reaction such as a rash beyond the injection area, difficulty breathing or swelling of the face. These are not common, but they need clinical assessment rather than watchful waiting at home.
The symptom that carries the most urgency is severe stomach pain that radiates towards the back. Acute pancreatitis is a rare but serious risk with GLP-1 medicines, and the MHRA issued a specific Drug Safety Update in January 2026 recommending patients seek urgent medical help for this symptom, with or without vomiting. Any suspected side effects from Wegovy can also be reported directly at the MHRA's Yellow Card scheme, which monitors the safety of medicines in real-world use.
Clinically, the licensed sites (thigh, abdomen, upper arm) produce similar semaglutide absorption, so there is no hierarchy in terms of weight-loss outcomes. The choice is almost entirely practical. The abdomen is often described as the easiest site to pinch and inject into, but some people simply find it uncomfortable or prefer not to use that area. The upper arm is convenient if someone else is injecting but awkward to self-administer. The thigh wins on visibility: you can watch the whole process, which tends to reduce anxiety after the first couple of injections.
If you are also taking an oral contraceptive pill, it is worth knowing that the NHS advises using an additional non-oral method of contraception during the first four weeks of Wegovy treatment, because GI effects can potentially affect absorption of oral medicines. This is particularly relevant for tirzepatide (Mounjaro) and applies for four weeks after each dose increase; for semaglutide the evidence is less clear, but your prescriber is the right person to ask. For a broader picture of what thigh-site technique looks like across semaglutide products, that page draws the distinction between the injection approach and the licensing differences clearly.
Wegovy is a prescription-only medicine. Whether you are starting treatment or thinking about switching sites, a prescriber needs to be involved, not for the injection technique itself, but because suitability and dose management require ongoing clinical review. If you haven't started yet and want to understand your options, checking your eligibility with our clinical team is the first step. Treatment pricing and what is included in a private prescription are explained on the Wegovy cost page, if that's useful context before you book. Our clinical team's background is on the prescribers page if you'd like to know more about who reviews consultations.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.